Not currently recruiting at UCSF
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Robert Bhisitkul
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Robert Bhisitkul
Professor, Ophthalmology. Authored (or co-authored) 56 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT03683251
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated